Metabolomic Signatures of Relapse and Survival in AML Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation
: Metabolomic profiling nominated candidate metabolites for validation in larger prospective studies and elucidated mechanistic pathways, potentially informing novel interventions or risk-adapted monitoring strategies in HSCT.
Authors
- Gary D. Bader (ORCID: https://orcid.org/0000-0003-0185-8861)
- Courtney L. Jones (ORCID: https://orcid.org/0000-0003-0672-1493)
- Caden Chiarello (ORCID: https://orcid.org/0009-0008-0522-5256)
- Julie A. Reisz
- Changjiang Xu
- Igor Novitzky-Basso
- Angelo D’Alessandro
- Jonas Mattsson
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Hematology Reports
- Published
- 2026-04-07
- DOI
- https://doi.org/10.3390/hematolrep18020027
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00